Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)
55.15
+0.15 (0.27%)
Mar 3, 2025, 4:08 PM HKT
HKG:6821 Revenue
Asymchem Laboratories (Tianjin) had revenue of 1.39B CNY in the quarter ending September 30, 2024, a decrease of -19.13%. This brings the company's revenue in the last twelve months to 5.57B, down -36.70% year-over-year. In the year 2023, Asymchem Laboratories (Tianjin) had annual revenue of 7.83B, down -23.70%.
Revenue (ttm)
5.57B CNY
Revenue Growth
-36.70%
P/S Ratio
n/a
Revenue / Employee
569.20K CNY
Employees
9,788
Market Cap
30.17B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.83B | -2.43B | -23.70% |
Jan 1, 2023 | 10.26B | 5.62B | 121.40% |
Dec 31, 2021 | 4.63B | 1.50B | 47.67% |
Dec 31, 2020 | 3.14B | 676.74M | 27.51% |
Dec 31, 2019 | 2.46B | 625.11M | 34.07% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
JD Health International | 58.84B |
Hansoh Pharmaceutical Group Company | 13.00B |
WuXi Biologics | 18.39B |
Alibaba Health Information Technology | 31.39B |
Innovent Biologics | 8.01B |
Akeso | 2.01B |
Sinopharm Group | 634.32B |